Form D · Other
Small Pharma Financing Inc.
Vancouver, A1 · CIK 0001851925
Offering snapshot reported Mar 24, 2021 · SEC filing
- Reported sold
- $35.1M Offering amount: $35.1M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 9, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 24, 2021 | Initial | $35,061,603 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.45M
- Finders' fees
- $0
- Form D file number
- 021-393302
Subscription Receipts at $0.96CDN. Each subscription receipt converts into one common share of issuer without additional consideration upon satisfaction of certain conditions.
Subscription Receipts at $0.96CDN. Each subscription receipt converts into one common share of issuer without additional consideration upon satisfaction of certain conditions.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Canaccord Genuity Corp. | None | Canaccord Genuity LLC · CRD 1020 |
Source: Form D, filed Mar 24, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Harry Chew | Director |
| Peter Rand | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
25 Th Floor, 700 West Georgia Street
Vancouver, A1, V7Y 1B3
Vancouver, A1, V7Y 1B3